PGI19 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PRIVATE PAYER PERSPECTIVE IN BRAZIL
May 1, 2010, 00:00
10.1016/S1098-3015(10)72338-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)72338-X/fulltext
Title :
PGI19 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PRIVATE PAYER PERSPECTIVE IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72338-X&doi=10.1016/S1098-3015(10)72338-X
First page :
Section Title :
Open access? :
No
Section Order :
938